These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 748137)
21. Urinary hydroxyproline and glycosaminoglycan excretion in Down's syndrome. Klujber L; Méhes K Z Kinderheilkd; 1973; 114(3):205-9. PubMed ID: 4269247 [No Abstract] [Full Text] [Related]
22. [Renal oxyproline, acid mucopolysaccharide and pyrophosphate elimination in senile osteoporosis and secondary forms of osteoporosis]. Mühlbach R; Schmidt UJ; Brüschke G; Lindenhayn K; Kalbe I; Reitzig P; Grossmann I Dtsch Gesundheitsw; 1970 Nov; 25(45):2154. PubMed ID: 4321174 [No Abstract] [Full Text] [Related]
23. [Content of sulphated glycosaminoglycans in blood serum and urinary excretion of oxyproline in patients with diabetes mellitus]. Dozorets IuL; Okorokov AN; Bobkov VIa Vrach Delo; 1976 Apr; (4):92-4. PubMed ID: 1007213 [No Abstract] [Full Text] [Related]
24. Myotonic dystrophy with no trinucleotide repeat expansion. Thornton CA; Griggs RC; Moxley RT Ann Neurol; 1994 Mar; 35(3):269-72. PubMed ID: 8122879 [TBL] [Abstract][Full Text] [Related]
25. [Biochemical study of Marfan's syndrome]. Deckers PF Presse Med (1893); 1971 Sep; 79(37):1639-40. PubMed ID: 4255353 [No Abstract] [Full Text] [Related]
26. [Activity of alpha 1-antitrypsin and alpha 2-macroglobulin and excretion of metabolites of the connective tissue in patients with pulmonary tuberculosis]. Kaminskaia GO; Muminov TA; Zhukova NL Ter Arkh; 1986; 58(4):110-3. PubMed ID: 2424112 [No Abstract] [Full Text] [Related]
27. [Significance of serum proteinase inhibitors in pulmonary tuberculosis]. Kaminskaia GO; Muminov TA; Zhukova NL Klin Med (Mosk); 1984 Dec; 62(12):89-91. PubMed ID: 6084096 [No Abstract] [Full Text] [Related]
28. Effect of vitamin D deficiency on urinary excretion of connective tissue derivatives (hydroxyproline and glycosaminoglycans) in rats. Dupuis Y; Digaud A; Gaudin-Harding F Calcif Tissue Int; 1981; 33(2):177-80. PubMed ID: 6783274 [TBL] [Abstract][Full Text] [Related]
29. Breathing during sleep in patients with myotonic dystrophy and non-myotonic respiratory muscle weakness. Gilmartin JJ; Cooper BG; Griffiths CJ; Walls TJ; Veale D; Stone TN; Osselton JW; Hudgson P; Gibson GJ Q J Med; 1991 Jan; 78(285):21-31. PubMed ID: 1670061 [TBL] [Abstract][Full Text] [Related]
30. Bite force and handgrip force in patients with molecular diagnosis of myotonic dystrophy. Guimaraes AS; Carlsson GE; Marie SK J Oral Rehabil; 2007 Mar; 34(3):195-200. PubMed ID: 17302947 [TBL] [Abstract][Full Text] [Related]
31. Myotonic dystrophy: relative sensitivity of symptoms signs and abnormal investigations. Avaria M; Patterson V Ulster Med J; 1994 Oct; 63(2):151-4. PubMed ID: 8650827 [TBL] [Abstract][Full Text] [Related]
35. New biochemical aspect of idiopathic pulmonary haemosiderosis in infancy. Kaiser E; Klujber L; Sulyok E Acta Paediatr Acad Sci Hung; 1970; 11(3):253-5. PubMed ID: 4259790 [No Abstract] [Full Text] [Related]
36. Whole body insulin resistance in myotonic dystrophy. Moxley RT; Corbett AJ; Minaker KL; Rowe JW Ann Neurol; 1984 Feb; 15(2):157-62. PubMed ID: 6367619 [TBL] [Abstract][Full Text] [Related]
37. Urine and tissue glycosaminoglycans and their interrelations. Poulsen JH Dan Med Bull; 1986 Apr; 33(2):75-96. PubMed ID: 3709239 [No Abstract] [Full Text] [Related]
38. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Thornton CA; Johnson K; Moxley RT Ann Neurol; 1994 Jan; 35(1):104-7. PubMed ID: 8285579 [TBL] [Abstract][Full Text] [Related]